Related Experiment Video

Updated: Jul 9, 2026

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
11:10

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

Avoidance of hypoglycemia restores hypoglycemia awareness by increasing beta-adrenergic sensitivity in type 1

A Fritsche1, N Stefan, H Häring

  • 1Medizinische Universitätsklinik Tübingen, Otfried-Müller-Strabetae 10, 72076 Tübingen, Germany.

Annals of Internal Medicine
|May 1, 2001
PubMed
Abstract

Insights

Reducing hypoglycemia episodes in type 1 diabetes patients restores awareness by improving beta-adrenergic sensitivity. This study highlights a key mechanism for managing diabetes and preventing dangerous low blood sugar levels.

Area of Science:

  • Endocrinology
  • Metabolic Disorders
  • Diabetes Management

Background:

  • Hypoglycemia unawareness is a significant challenge in managing type 1 diabetes.
  • This lack of awareness can lead to recurrent episodes of low blood sugar, increasing patient risk.

Purpose of the Study:

  • To investigate if reducing hypoglycemia frequency can restore awareness in type 1 diabetes patients.
  • To determine if this restoration is mediated by enhanced beta-adrenergic sensitivity.

Main Methods:

  • A controlled interventional study involving 10 men with type 1 diabetes and hypoglycemia unawareness.
  • Participants strictly avoided hypoglycemia for 4 months.
  • Beta-adrenergic sensitivity was assessed using isoproterenol testing, and hypoglycemia awareness was evaluated via hypoglycemic clamp.

Main Results:

  • A significant reduction in weekly hypoglycemia episodes was observed (from 8.4 to 1.4).
  • Beta-adrenergic sensitivity, measured by isoproterenol dose, significantly improved, indicating restored physiological response.
  • Patients reported increased autonomic symptom scores during induced hypoglycemia, nearing levels of normal individuals.

Conclusions:

  • Strict avoidance of hypoglycemia can restore awareness in type 1 diabetes patients with unawareness.
  • The primary mechanism for this recovery appears to be an improvement in beta-adrenergic sensitivity.

More Related Videos

Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice07:35

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Published on: January 26, 2024

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...